Treating inflammatory conditions such as vaginosis, vaginitis, and vulvovaginitis in pregnancy is a special problem due to limitations of available drugs. However, possible treatment options can be found also in naturally originated products, such as essential oils (EOs) of different plants. The aim of this study was to evaluate in vitro antimicrobial and toxic activities of the commercial EO of Rosmarinus officinalis L. (Lamiaceae) against five Gram-positive and Gram-negative bacterial strains and two Candida strains obtained from pregnant women with vaginal infection. Gas chromatography-mass spectrometry of the tested EO revealed oxygenated monoterpenes to be the major ingredients, while microdilution assay showed the highest activity on Staphylococcus aureus II strain at 6.2 mg/mL. After 24 hours, toxicity was determined at 19.4 mg/mL on Artemia salina nauplii. The obtained results show this EO to be a promising alternative therapy for vaginal infections, although further toxicity and safety research is required.
Species of Lamiaceae are the most known sources of essential oils (EOs), among which the EO of Rosmarinus officinalis L. (commonly known as rosemary) is already well known for its antimicrobial activity. While carnosic and rosmarinic acid may be the main bioactive antimicrobial compounds present in rosemary extracts [1a] , antibacterial efficacy of rosemary essential oil is associated with the presence of compounds such as α-pinene, camphor and (-)-bornyl acetate [1b] . Furthermore, this EO expresses additional beneficial properties, such as improving circulation and relieving pain [1c], as well as having a potential anticarcinogenic activity [1d] . There is a rising need to investigate plants used in alternative therapies to determine if their use is based on the principles of evidence-based medicine [1e] . Novel natural agents will be useful in the upcoming post-antibiotic era, with the evident need for isolation of new compounds from natural products to which antimicrobial resistance has not been detected [1a] .
The genital inflammatory conditions, vaginosis, vaginitis, and vulvovaginitis, occur in more than 30% of the population of women in their reproductive years [1f] . Vaginosis is a genital inflammatory condition that occurs in women of all ages [1g] and is characterized by dysbiosis of the vaginal microbiome [1h] . The etiology of vaginosis is still not fully understood but it is most likely a result of changes in the vaginal pH, caused by substitution of the peroxideproducing Lactobacillus species with infective agents, both aerobic and anaerobic bacteria, and yeasts [1i]. One of the major problems with treating these conditions in pregnancy is that pregnancy itself limits the number of drugs that can be used, because of their potential teratogenic effect. The most commonly used antibiotics, such as penicillin-based drugs and metronidazole, as well as many antifungals, are increasingly less effective due to the increase of antimicrobial resistance to infectious agents [1e,1j]. However, possible treatment options can be found in various plant products, such as EOs, extracts, and tinctures. Some traditional medical practices have used such products because of their healing properties for centuries, but it is only recently that we have started to determine, isolate and understand the mechanism of action of active compounds in these products. By knowing which molecule or, even better, what specific combination of molecules, contributes the most to the antimicrobial effect of certain natural products, we can test and recommend their use in accordance with the principles of evidence-based medicine [1k] . The aim of this research was to evaluate in vitro possible antimicrobial and toxic activities of the commercial EO of R. officinalis against bacterial and Candida strains isolated from pregnant women with vaginal infection and to assess its possible application as an alternative treatment for inflammatory gynecological diseases.
The chemical composition of the EO determined with GC/MS is given in Table 1 . Oxygenated monoterpenes were the major compounds. This finding is in agreement with the study of Hussain et al. [2a] in which the tested R. officinalis EO from Pakistan contained a high concentration of oxygenated monoterpenes (61.7%). Similarly, Teixeira et al. [2b] reported that the rosemary EO they analyzed contained 59.7% of oxygenated monoterpenes, which is also consistent with our findings. The major components were eucalyptol (39.0% GC/MS; 42.2% GC/FID), camphor (13.7% GC/MS; 11.6% GC/FID), -pinene (10.3% GC/MS; 12.1% GC/FID), (1S)-(-)-β-pinene (7.2% GC/MS; 8.2% GC/FID) and endo-borneol (4.7% GC/MS; 4.3% GC/FID). Similarly, several published papers reported that the major components of R. officinalis EO were eucalyptol (29.2%), camphor (17.2%) and α-pinene (11.5%) [2c-2e]. The variations in the main constituent (eucalyptol and camphor) concentrations could be explained by 2017 Vol. 12 No. 1 127 -130 [3c] investigated pure rosmarinic acid against Grampositive bacteria and found it much less effective than crude EO. Our examined rosemary EO exhibited a higher and selective antibacterial activity against the Gram-positive bacteria (Table 2) , with the MIC and MBC values ranging from 6.2 to 50 mg/mL. The strongest antibacterial activity of the EO was obtained against S. aureus II, with MIC/MBC values of 6.2 mg/mL, while its resistance to common antibiotics was higher than that of S. aureus I.
In another study, Hammer et al. [3a] determined that rosemary EO possesses a considerable antimicrobial activity against E. coli, P. aeruginosa, and S. aureus, while our EO showed significant inhibition of growth of S. aureus and only a modest activity against E. coli. In our research, we did not detect any antimicrobial effect of rosemary EO on the P. aeruginosa isolate, whereas MIC/MBC activity was recorded against P. mirabilis (25 mg/mL). This difference compared with the latter study may be due to different origins of the isolates. Hammer et al. [3a] used attested isolates, while we used clinical isolates. According to some other studies, EOs exhibit a stronger activity to Gram-positive bacteria [2a,2b] .
In our study the analyzed rosemary EO reached MIC/MBC values for the S. aureus I isolate of 25 mg/mL, while in other studies rosemary EOs achieved MIC/MBC against attested S. aureus at 0.3 mg/mL [2c] , indicating that the clinical isolates used in our study had strong antimicrobial resistance. Furthermore, the fact that the isolated clinical strains of E. coli I and E. coli II were resistant to the commercial antibiotics used in our study but sensitive to the EO, which showed MIC and MBC/MFC values of 12.5 and 25 mg/mL, respectively, is of particular significance. This may be due to synergistic effects of the mixture of various chemical compounds, or it may be supposed that the effectiveness of EOs depends not only on their chemical composition but also on other conditions, such as pH of broth medium and strain-specific characteristics of the microorganisms [3d]. LC 50 values in the toxicity assay after 24 and 48 hours were 19.4 mg/mL and 5.4 mg/mL, respectively. Prolonged exposure to the EO (from 24 to 48 hours) resulted in increased brine shrimp mortality.
There was a high linear correlation between the EO concentration and mortality after 24 (r 2 = 0.9) and 48 hours (r 2 = 0.8). These results indicate that increased EO concentrations (3.1 -50 mg/mL) lead to an increase in EO toxicity (from 43% to 95% after 24-hour incubation and from 65% to 97% after 48-hour incubation). The brine shrimp bioassay is a quick and cheap test for establishing acute toxicity of EO. Parra et al.
[3e] found a high correlation between in vivo and in vitro tests (r = 0.8, p < 0.05). Considering that EO toxicity increased with higher concentrations and a longer exposure time, it is necessary to be careful with EO dosage and application.
Our results are in agreement with the results of a previous study reporting eucalyptol and camphor to be the most prevalent constituents [3f]. However, the fact that they were the most prevalent does not necessarily mean that these compounds were responsible for the recorded antimicrobial activity. Actually, some studies have shown that carnosol, carnosic acid, and rosmarinic acid possess major antibacterial [3g], antioxidant and anti-inflammatory properties [3h 3i]. In the study of Jordan et al.
[3j] carnosic acid was the major component credited for bacteriostatic effects. Hence, any study of EOs should take into account that each EO is specific and its composition depends on the plant it was derived from and on the type of extraction procedure applied [3a,3l] .
Furthermore, the antimicrobial effect of EOs cannot be explained by a single mechanism of action or with a single active compound. It is considered that all the antiviral, antifungal and antimicrobial effects of EOs are due to synergistic effects of their numerous bioactive constituents [3d].
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Promising results were seen in studies comparing the standard antimicrobial drug ciprofloxacin and rosemary oil [3e]. Moreover, some studies evaluating the synergistic effect of antibiotics and rosemary EO found that the combination of the EO with aminoglycoside antibiotics could achieve a better effect against multidrug-resistant S. aureus and E. coli [3k,3l] than antibiotics alone. Further research which would clarify the underlying mechanism of the synergy is therefore recommended.
Our results showed a significant in vitro antimicrobial activity of the R. officinalis EO on clinically isolated vaginal bacterial and Candida strains. We may conclude that the EO represents a potential alternative therapy for vaginal infections, when used in appropriate doses. Future research should include a wider range of bacteria and Candida strains, and explore the synergistic effects with common antimicrobial drugs, as well as cytotoxic activity of rosemary EO, preferably in in vivo studies.
Experimental

Essential oils and GC/MS analysis:
The analyzed commercial EO of R. officinalis was purchased from MeiLab (Belgrade, Serbia, serial number ER010514) and obtained by steam distillation of the leaves and buds and stored in a refrigerator at +4°C prior to the analysis. The chemical composition was analyzed using a gas chromatography-mass spectrometry (GC/MS) after preparation by using dilution of oil with dichloromethane (1:10, w/v) and the trials were performed on an Agilent capillary gas chromatograph coupled with ta mass spectrometer (MSD) (model GC Agilent 7890A; MS 5975C). A non-polar capillary column (HP-5MS, fused silica) was used with these parameters: oven temperature was changed during a 30-min run time in the following procedure: from 50°C (for 1 min) to 100°C at 5°C/min and to 200°C at 9°C/min with the final temperature kept for 7.89 min; temperature of the injector was 250°C, with helium as carrier gas (constant flow mode, flow rate was 0.8 mL/min), split injection technique (50 : 1); ionization energy 70 eV, in the EI ionization mode; ion source temperature was 230°C; scan mass range of m/z 30-550 and interface line temperature 280°C. Identification of the EO components was made from their retention indexes (RI) and by comparing their mass spectra, using the Wiley Registry of Mass Spectral Data, 7th edition, NIST8 Mass Spectral Library. The other components were identified by comparison of their spectral data and RI with the literature data (our own laboratory database and mass spectra generated by the instrument software -NIST mass spectrometry and MSD ChemStation E.02.00.493), after which all identified components were confirmed by the AMDIS software program (version 2.66). The proportion of the components was obtained from the electronic integration of the MSD signals of specific ion representation.
Essential oil and GC/FID analysis:
Samples of the same EO were analyzed by gas chromatography (GC) with the use of a flame ionization detector (model GC Hewlett Packard 6890; FID). Retention indices were determined with a mixture of n-alkanes (C9 -C18) under the same experimental conditions. The preparation of the EO for the GC/FID analysis involved dilution of dichloromethane (1:10, w/v), and the trials were performed on a Hewlett Packard capillary gas chromatograph coupled with FID non-polar capillary column (HP-5MS 60 m, 320 m ID, 0.2 µm film thickness, fused silica) used with these parameters: oven temperature was changed during the 35-min run time in the following procedure: from 50°C (for 1 min) to 100°C at 5°C/min and to 200°C at 9°C/min with the final temperature kept for 12.9 min; temperature of the injector was 250°C, with helium as the carrier gas (constant pressure mode; pressure was 13.8 psi), split injection technique (10 : 1); detector temperature 300°C, hydrogen flow 40.0 mL/min, air flow 450.0 mL/min, constant makeup flow 45.0 mL/min. Validation (and relative composition in %) of identified components was performed by GC with FID (GC/FID) and compared with experimentally acquired retention indices. Brine shrimp toxicity assay: Toxicity of the investigated rosemary EO was made by Artemia salina bioassay according to Meyer et al. [3n] . In each microwell of the plate, 10 larvae were added. The wells already contained 25 µL of specific EO dilution in 1% (DMSO) and 225 µL of artificial sea water (ASW). LC 50 values of EO were determined by serial double dilutions in 6 repetitions (3.1 -50 mg/mL). A mixture of 25 µL 1% DMSO (oil emulsifier) and 225 µL ASW with larvae was used as a control. For toxin control, microcystin standard MCYST-LR (SigmaAldrich, Germany) was used. Microplates were incubated under a lamp, at 30°C, without feeding the shrimps. Acute toxicity was calculated after 24 and 48 h, by counting dead nauplii. Surviving shrimps were counted under a stereomicroscope (Zeiss, Germany) and afterwards, 50 µL of methanol was added to each well. All the tests were repeated twice and performed in triplicate. Abbott's equation was applied to calculate the mortality rate: Mortality (%) = ((n test -n control)/n control) x 100, where n control and n test were the numbers of dead larvae in the first test and control tests. Toxicity was expressed as LC 50 (mg/mL). LC 50 represented the lethal concentration required to kill 50% of the population of test brine shrimps, Artemia salina.
Statistical analyses:
Statistical analyses of the data were performed by analysis of variance (ANOVA), using Microsoft Excel XP. Duncan's multiple range test was applied for the determination of significant differences between results (p < 0.05) in the antimicrobial testing using Analytical Software Statistica 8.1.
